Rare Cancer News & Clinical Trials » Trial - Adenoid Cystic Carcinoma

Feeds

40322 items (40322 unread) in 74 feeds

Acinar Cell Carcinoma (947 unread)

• Google - Acinar Cell Carcinoma (826 unread)
• PubMed - Acinar Cell Carcinoma (112 unread)
• Trial - Acinar Cell Carcinoma (9 unread)

Acinic Cell Carcinoma (353 unread)

• Google - Acinic Cell Carcinoma (212 unread)
• PubMed - Acinic Cell Carcinoma (141 unread)
• Trial - Acinic Cell Carcinoma

Adenoid Cystic Carcinoma (509 unread)

• Google - Adenoid Cystic Carcinoma (483 unread)
• PubMed - Adenoid Cystic Carcinoma (4 unread)
• Trial - Adenoid Cystic Carcinoma (22 unread)

Adrenal Gland Cancer (3507 unread)

• Google - Adrenal Cancer (1769 unread)
• Google - Adrenocortical Carcinoma (665 unread)
• PubMed - Adrenal Cancer (695 unread)
• PubMed - Adrenocortical Carcinoma (195 unread)
• Trial - Adrenal Cancer (139 unread)
• Trial - Adrenocortical Carcinoma (44 unread)

Ampulla Of Vater (575 unread)

• Google - Ampullary Cancer (464 unread)
• PubMed - Ampullary Cancer (102 unread)
• Trial - Ampullary Carcinoma (9 unread)

Anal Cancer (3208 unread)

• Google - Anal Cancer (1567 unread)
• PubMed - Anal Cancer (1485 unread)
• Trial - Anal Cancers (156 unread)

Angiosarcoma (1004 unread)

• Google - Angiosarcoma (634 unread)
• PubMed - Angiosarcoma (348 unread)
• Trial - Angiosarcoma (22 unread)

Appendix Cancer (1264 unread)

• Google - Appendix Cancer (948 unread)
• PubMed - Appendix Cancer (235 unread)
• Trial - Appendix Cancer (81 unread)

Bile Duct Cancer (5441 unread)

• Google - Bile Duct Cancer (1583 unread)
• Google - Cholangiocarcinoma (1264 unread)
• PubMed - Bile Duct Cancer (657 unread)
• PubMed - Cholangiocarcinoma (1454 unread)
• Trial - Bile Duct Cancer (264 unread)
• Trial - Cholangiocarcinoma (219 unread)

Brain and CNS (7735 unread)

• Google - Rare Brain Tumor (2323 unread)
• Google - Rare CNS Tumor (1892 unread)
• PubMed - Ganglioglioma (52 unread)
• PubMed - Rare Brain Tumor (678 unread)
• PubMed - Rare CNS Tumor (423 unread)
• Trial - Brain Tumor (1235 unread)
• Trial - CNS Tumor (1126 unread)
• Trial - Ganglioglioma (6 unread)

Carcinoid (859 unread)

• Google - Carcinoid (570 unread)
• PubMed - Carcinoid (281 unread)
• Trials - Carcinoid (8 unread)

Endocrine/Neuroendocrine (6661 unread)

• Google - Merkel Cell Cancer (983 unread)
• Google - Neuroendocrine Tumor (1451 unread)
• PubMed - Merkel Cell Cancer (202 unread)
• PubMed - Neuroendocrine Tumor (3249 unread)
• Trial - Merkel Cell Cancer (54 unread)
• Trial - Neuroendocrine Cancers (722 unread)

Gall Bladder Cancer (1824 unread)

• Google - Gall Bladder Cancer (1458 unread)
• PubMed - Gall Bladder Cancer (289 unread)
• Trials - Gall Bladder Cancer (77 unread)

Hemangioendothelioma (1750 unread)

• Google - Hemangioendothelioma (884 unread)
• PubMed - Hemangioendothelioma (856 unread)
• Trial - Hemangioendothelioma (10 unread)

Hepatoblastoma (545 unread)

• Google - Hepatoblastoma (342 unread)
• PubMed - Hepatoblastoma (178 unread)
• Trial - Hepatoblastoma (25 unread)

Pancreas (607 unread)

• Google - Insulinoma (408 unread)
• PubMed - Insulinoma (192 unread)
• Trial - Insulinoma (7 unread)

Phyllodes (491 unread)

• Google - Phyllodes Tumor (391 unread)
• PubMed - Phyllodes Tumor (100 unread)
• Trial - Phyllodes

PMP and Mucinous Tumors (396 unread)

• Google - Pseudomyxoma Peritonei (308 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (79 unread)
• Trial - Pseudomyxoma Peritonei (9 unread)

Rhabdomyosarcoma (1282 unread)

• "rhabdomyosarcoma" - Google News (806 unread)
• PubMed - Rhabdomyosarcoma (410 unread)
• Trial - Rhabdomyosarcoma (66 unread)

Sarcoma (1364 unread)

• "sarcoma" - Google News (801 unread)
• PubMed - Sarcoma (538 unread)
• Trial - Sarcoma (25 unread)

Trial - Adenoid Cystic Carcinoma (22 unread)

• 

  Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

  Posted: November 6th, 2023, 3:00am GMT

  Conditions: Adenoid Cystic Carcinoma; Metastatic Adenoid Cystic Carcinoma; Recurrent Adenoid Cystic Carcinoma
  Interventions: Drug: REM-422
  Sponsors: Remix Therapeutics
  Not yet recruiting
• 

  Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

  Posted: July 4th, 2023, 2:00pm GMT

  Condition:   Adenoid Cystic Carcinoma of the Head and Neck
  Interventions:   Drug: OBT076;   Drug: Balstilimab
  Sponsor:   Groupe Oncologie Radiotherapie Tete et Cou
  Not yet recruiting
• 

  A Phase 1/2 Study CB-103 With or Without Venetoclax in Patients With NOTCH ACC

  Posted: March 20th, 2023, 2:00pm GMT

  Conditions:   Adenoid Cystic Carcinoma;   Metastatic Adenoid Cystic Carcinoma;   Recurrent Adenoid Cystic Carcinoma
  Interventions:   Drug: CB-103;   Drug: Venetoclax;   Drug: Lenvatinib
  Sponsors:   Glenn J. Hanna;   Adenoid Cystic Carcinoma Research Foundation;   Cellestia Biotech AG
  Recruiting
• 

  Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma

  Posted: February 17th, 2023, 3:00pm GMT

  Conditions:   Carcinoma, Adenoid Cystic;   Head and Neck Cancer
  Intervention:   Radiation: simultaneous integrated boost of carbon ions radiation therapy
  Sponsor:   CNAO National Center of Oncological Hadrontherapy
  Not yet recruiting
• 

  Amivantamab in Adenoid Cystic Carcinoma

  Posted: October 12th, 2021, 2:00am GMT

  Conditions: Salivary Gland Cancer
  Interventions: Drug: Amivantamab
  Sponsors: Trisha Wise-Draper
  Recruiting
• 

  9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

  Posted: August 18th, 2021, 2:00am GMT

  Conditions: Salivary Gland Cancer; Recurrent Salivary Gland Cancer; Metastatic Cancer; Adenoid Cystic Carcinoma
  Interventions: Drug: 9-ING-41; Drug: Carboplatin
  Sponsors: Glenn J. Hanna; Actuate Therapeutics Inc.
  Recruiting
• 

  Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

  Posted: July 23rd, 2021, 2:00pm GMT

  Condition:   Carcinoma, Adenoid Cystic
  Intervention:   Drug: EGFR-TK Inhibitor
  Sponsor:   Qingdao Central Hospital
  Recruiting
• 

  AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer

  Posted: July 22nd, 2021, 2:00pm GMT

  Conditions: Adenoid Cystic Carcinoma; Metastatic Adenoid Cystic Carcinoma
  Interventions: Drug: AL101; Procedure: Therapeutic Conventional Surgery
  Sponsors: M.D. Anderson Cancer Center
  Recruiting
• 

  Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

  Posted: May 12th, 2021, 2:00am GMT

  Conditions: Adenoid Cystic Carcinoma; Metastatic Adenoid Cystic Carcinoma
  Interventions: Other: Standard of Care; Radiation: SBRT
  Sponsors: Dana-Farber Cancer Institute; Adenoid Cystic Carcinoma Research Foundation; Gateway for Cancer Research
  Recruiting
• 

  A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma

  Posted: January 22nd, 2021, 3:00pm GMT

  Conditions: Relapsed Solid Tumors; Refractory Solid Tumors; Non-Hodgkin Lymphoma
  Interventions: Drug: KB-0742
  Sponsors: Kronos Bio
  Recruiting
• 

  Understanding the Burden of ACC Through the Eyes of Patients

  Posted: January 13th, 2021, 3:00am GMT

  Conditions: Adenoid Cystic Carcinoma
  Sponsors: Ayala Pharmaceuticals, Inc,; Adenoid Cystic Carcinoma Research Foundation; Memorial Sloan Kettering Cancer Center; Hadassah Medical Organization; Engage Health Inc.
  Completed
• 

  Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation

  Posted: January 2nd, 2020, 3:00am GMT

  Conditions: Adenoid Cystic Carcinoma
  Interventions: Radiation: Carbon ion irradiation; Radiation: Bimodal irradiation
  Sponsors: Heidelberg University
  Recruiting
• 

  Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

  Posted: October 28th, 2019, 2:00pm GMT

  Conditions:   Non Small Cell Lung Cancer;   Advanced Solid Tumor;   Metastatic Melanoma;   Metastatic Head and Neck Carcinoma;   Metastatic Renal Cell Carcinoma;   Metastatic Colorectal Cancer;   Sarcomas;   Metastatic Prostate Cancer;   Ovarian Cancer;   Small Cell Lung Cancer;   Metastatic Breast Cancer;   Pancreas Cancer;   Gastric Cancer;   Esophageal Cancer;   Gastroesophageal Junction Adenocarcinoma;   Cervical Cancer;   Adenoid Cystic Carcinoma;   Salivary Gland Cancer;   Urothelial Carcinoma
  Interventions:   Drug: ONC-392;   Drug: Pembrolizumab
  Sponsors:   OncoC4, Inc.;   National Cancer Institute (NCI)
  Recruiting
• 

  The Registry of Oncology Outcomes Associated With Testing and Treatment

  Posted: July 22nd, 2019, 2:00am GMT

  Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
  Interventions: Diagnostic Test: Biomarker Testing (L); Drug: Systemic Treatment (T); Other: Patient Reported Outcomes (P)
  Sponsors: Taproot Health
  Recruiting
• 

  Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

  Posted: June 19th, 2019, 2:00am GMT

  Conditions: Metastatic Adenoid Cystic Carcinoma; Progressive Disease; Recurrent Adenoid Cystic Carcinoma
  Interventions: Drug: Avelumab; Drug: Axitinib
  Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
  Completed
• 

  APG-115 in Salivary Gland Cancer Trial

  Posted: December 20th, 2018, 3:00pm GMT

  Conditions:   Malignant Salivary Gland Cancer;   Salivary Gland Cancer
  Interventions:   Drug: APG-115;   Drug: Carboplatin
  Sponsors:   University of Michigan Rogel Cancer Center;   Ascentage Pharma Group Inc.
  Recruiting
• 

  Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  Posted: June 14th, 2018, 2:00pm GMT

  Conditions: Any Solid Tumors Progressed After a Prior Immunotherapy; Cervical Cancer; Adenoid Cystic Carcinoma; Squamous Cell Carcinoma of Head and Neck; Mesothelioma; Gall Bladder Cancer; Thymic Carcinoma; Non-Small Cell Squamous Lung Cancer; Bladder Cancer; Ovarian Cancer; Pancreatic Cancer; Colon Cancer; Leiomyosarcoma; Head and Neck Squamous Cell Carcinoma; Thymoma; Urothelial Carcinoma
  Interventions: Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
  Sponsors: VM Oncology, LLC
  Recruiting
• 

  A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

  Posted: September 7th, 2017, 2:00am GMT

  Conditions: Paranasal Sinus Cancer; Nasal Cavity Tumor; Nasal Cavity Adenocarcinoma
  Interventions: Drug: Cisplatin; Radiation: Adjuvant Proton Radiotherapy; Procedure: Endoscopic Resection; Drug: cisplatin and etoposide
  Sponsors: Memorial Sloan Kettering Cancer Center
  Completed
• 

  Study of E7389 Liposomal Formulation in Participants With Solid Tumor

  Posted: July 5th, 2017, 2:00am GMT

  Conditions: Solid Tumor
  Interventions: Drug: E7389-LF
  Sponsors: Eisai Co., Ltd.
  Active, not recruiting
• 

  Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

  Posted: December 1st, 2016, 3:00am GMT

  Conditions: Adenoid Cystic Skin Carcinoma; Adnexal Carcinoma; Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Apocrine Carcinoma; Cylindrocarcinoma; Digital Papillary Adenocarcinoma; Endocrine Mucin-Producing Sweat Gland Carcinoma; Extramammary Paget Disease; Extraocular Cutaneous Sebaceous Carcinoma; Hidradenocarcinoma; Keratoacanthoma; Malignant Sweat Gland Neoplasm; Merkel Cell Carcinoma; Microcystic Adnexal Carcinoma; NK-Cell Lymphoma, Unclassifiable; Papillary Adenocarcinoma; Porocarcinoma; Primary Cutaneous Mucinous Carcinoma; Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Anaplastic Large Cell Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Refractory Merkel Cell Carcinoma; Refractory Mycosis Fungoides; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Skin Squamous Cell Carcinoma; Refractory T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome; Signet Ring Cell Carcinoma; Skin Basal Cell Carcinoma; Skin Basosquamous Cell Carcinoma; Skin Squamous Cell Carcinoma; Spiradenocarcinoma; Squamoid Eccrine Ductal Carcinoma; Squamous Cell Carcinoma of Unknown Primary; Sweat Gland Carcinoma; Trichilemmal Carcinoma; Vulvar Squamous Cell Carcinoma
  Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Procedure: Positron Emission Mammography; Biological: Talimogene Laherparepvec
  Sponsors: National Cancer Institute (NCI)
  Active, not recruiting
• 

  Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

  Posted: April 27th, 2012, 2:00am GMT

  Conditions: Adenoid Cystic Carcinoma; Squamous Cell Carcinoma; Sinonasal Carcinoma; Sinonasal Undifferentiated Carcinoma; Mucoepidermoid Carcinoma; Schneiderian Carcinoma; Myoepithelial Carcinoma; Esthesioneuroblastoma; Melanoma
  Interventions: Radiation: Proton radiation therapy; Radiation: Intensity-modulated radiotherapy
  Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Cancer Institute (NCI)
  Active, not recruiting
• 

  Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

  Posted: May 12th, 2009, 2:00pm GMT

  Condition:   Head and Neck Cancer
  Interventions:   Other: biologic sample preservation procedure;   Other: medical chart review
  Sponsors:   Vanderbilt University Medical Center;   National Cancer Institute (NCI)
  Recruiting